Cancer-associated fibroblasts connect metastasispromoting communication in colorectal cancer

Frontiers in Oncology

Volumn 5, Issue , 2015, Pages

  Tommelein, Joke ^a   Verset, Laurine ^b   Boterberg, Tom ^a   Demetter, Pieter ^b   Bracke, Marc ^a   De Wever, Olivier ^a  

^a GHENT UNIVERSITY   (Belgium)

^b ERASME HOSPITAL   (Belgium)

Author keywords

Cancer associated fibroblasts; Colorectal cancer; Immune cells; Metastasis; Pericryptal fibroblasts

Indexed keywords

EID: 85016222078     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2015.00063     Document Type: Review

References (65)

1. Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin (2014) 64:104-17. doi:10.3322/caac.21220
2. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin (2014) 64:9-29. doi:10.3322/caac.21208
3. Conti J, Thomas G. The role of tumour stroma in colorectal cancer invasion and metastasis. Cancers (Basel) (2011) 3:2160-8. doi:10.3390/cancers3022160
4. Herrera M, Islam AB, Herrera A, Martin P, Garcia V, Silva J, et al. Functional heterogeneity of cancer-associated fibroblasts from human colon tumors shows specific prognostic gene expression signature. Clin Cancer Res (2013) 19:5914-26. doi:10.1158/1078-0432.CCR-13-0694
5. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell (2011) 144:646-74. doi:10.1016/j.cell.2011.02.013
6. Martin M, Pujuguet P, Martin F. Role of stromal myofibroblasts infiltrating colon cancer in tumor invasion. Pathol Res Pract (1996) 192:712-7. doi:10.1016/s0344-0338(96)80093-8
7. Adegboyega PA, Mifflin RC, Dimari JF, Saada JI, Powell DW. Immunohistochem-ical study of myofibroblasts in normal colonic mucosa, hyperplastic polyps, and adenomatous colorectal polyps. Arch Pathol Lab Med (2002) 126:829-36.
8. Saada JI, Pinchuk IV, Barrera CA, Adegboyega PA, Suarez G, Mifflin RC, et al. Subepithelial myofibroblasts are novel nonprofessional APCs in the human colonic mucosa. JImmunol (2006) 177:5968-79. doi:10.4049/jimmunol.177.9.5968
9. Mutoh H, Sakurai S, Satoh K, Osawa H, Tomiyama T, Kita H, et al. Pericryptal fibroblast sheath in intestinal metaplasia and gastric carcinoma. Gut (2005) 54:33-9. doi:10.1136/gut.2004.042770
10. Crivellato E, Finato N, Isola M, Pandolfi M, Ribatti D, Beltrami CA. Number of pericryptal fibroblasts correlates with density of distinct mast cell phenotypes in the crypt lamina propria ofhuman duodenum: Implications for the homeostasis of villous architecture. AnatRec A Discov Mol Cell Evol Biol (2006) 288:593-600. doi:10.1002/ar.a.20325
11. Direkze NC, Hodivala-Dilke K, Jeffery R, Hunt T, Poulsom R, Oukrif D, et al. Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res (2004) 64:8492-5. doi:10.1158/0008-5472.can-04-1708
12. Kikuchi Y, Kashima TG, Nishiyama T, Shimazu K, Morishita Y, Shimazaki M, et al. Periostin is expressed in pericryptal fibroblasts and cancer-associated fibroblasts in the colon. J Histochem Cytochem (2008) 56:753-64. doi:10.1369/jhc.2008.951061
13. Mueller L, Goumas FA, Affeldt M, Sandtner S, Gehling UM, Brilloff S, et al. Stromal fibroblasts in colorectal liver metastases originate from resident fibrob-lasts and generate an inflammatory microenvironment. Am J Pathol (2007) 171:1608-18. doi:10.2353/ajpath.2007.060661
14. Rupp C, Scherzer M, Rudisch A, Unger C, Haslinger C, Schweifer N, et al. IGFBP7, a novel tumor stroma marker, with growth-promoting effects in colon cancer through a paracrine tumor-stroma interaction. Oncogene (2014) 34:815-25. doi:10.1038/onc.2014.18
15. Herrera M, Herrera A, Dominguez G, Silva J, Garcia V, Garcia JM, et al. Cancer-associated fibroblast and M2 macrophage markers together predict outcome in colorectal cancer patients. CancerSci (2013) 104:437-44. doi:10.1111/cas.12096
16. Henriksson ML, Edin S, Dahlin AM, Oldenborg PA, Oberg A, Van Guelpen B, et al. Colorectal cancer cells activate adjacent fibroblasts resulting in FGF1/FGFR3 signaling and increased invasion. Am J Pathol (2011) 178:1387-94. doi:10.1016/j.ajpath.2010.12.008
17. Harper J, Sainson RC. Regulation of the anti-tumour immune response by cancer-associated fibroblasts. Semin Cancer Biol (2014) 25:69-77. doi:10.1016/j.semcancer.2013.12.005
18. Tsujino T, Seshimo I, Yamamoto H, Ngan CY, Ezumi K, Takemasa I, et al. Stromal myofibroblasts predict disease recurrence for colorectal cancer. Clin Cancer Res (2007) 13:2082-90. doi:10.1158/1078-0432.ccr-06-2191
19. Narunsky L, Oren R, Bochner F, Neeman M. Imaging aspects of the tumor stroma with therapeutic implications. Pharmacol Ther (2014) 141:192-208. doi:10.1016/j.pharmthera.2013.10.003
20. Nakagawa H, Liyanarachchi S, Davuluri RV, Auer H, Martin EW Jr, De La Chapelle A, et al. Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles. Oncogene (2004) 23:7366-77. doi:10.1038/sj.onc.1208013
21. Peddareddigari VG, Wang D, Dubois RN. The tumor microenvironment in colorectal carcinogenesis. Cancer Microenviron (2010) 3:149-66. doi:10.1007/s12307-010-0038-3
22. Hawinkels LJ, Paauwe M, Verspaget HW, Wiercinska E, Van Der Zon JM, Van Der Ploeg K, et al. Interaction with colon cancer cells hyperactivates TGF-beta signaling in cancer-associated fibroblasts. Oncogene (2014) 33:97-107. doi:10.1038/onc.2012.536
23. Kaler P, Owusu BY, Augenlicht L, Klampfer L. The role of STAT1 for crosstalk between fibroblasts and colon cancer cells. Front Oncol (2014) 4:88. doi:10.3389/fonc.2014.00088
24. De Boeck A, Hendrix A, Maynard D, Van Bockstal M, Daniels A, Pauwels P, et al. Differential secretome analysis of cancer-associated fibroblasts and bone marrow-derived precursors to identify microenvironmental regulators of colon cancer progression. Proteomics (2013) 13:379-88. doi:10.1002/pmic.201200179
25. Gong Y, Scott E, Lu R, Xu Y, Oh WK, Yu Q. TIMP-1 promotes accumulation of cancer associated fibroblasts and cancer progression. PLoS One (2013) 8:e77366. doi:10.1371/journal.pone.0077366
26. Valenciano A, Henriquez-Hernandez LA, Moreno M, Lloret M, Lara PC. Role of IGF-1 receptor in radiation response. Transl Oncol (2012) 5:1-9. doi:10.1593/tlo.11265
27. De Wever O, Nguyen QD, VanHoorde L, Bracke M, Bruyneel E, Gespach C, et al. Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac. FASEBJ (2004) 18:1016-8. doi:10.1096/fj.03-1110fje
28. De Boeck A, Pauwels P, Hensen K, Rummens JL, Westbroek W, Hendrix A, et al. Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1/HER3 signalling. Gut (2012) 62:550-60. doi:10.1136/gutjnl-2011-301393
29. Torres S, Bartolome RA, Mendes M, Barderas R, Fernandez-Acenero MJ, Pelaez-Garcia A, et al. Proteome profiling of cancer-associated fibroblasts identifies novel proinflammatory signatures and prognostic markers for colorectal cancer. Clin Cancer Res (2013) 19:6006-19. doi:10.1158/1078-0432.CCR-13-1130
30. Neufert C, Becker C, Tureci O, Waldner MJ, Backert I, Floh K, et al. Tumor fibroblast-derived epiregulin promotes growth of colitis-associated neoplasms through ERK. J Clin Invest (2013) 123:1428-43. doi: 10.1172/jci63748
31. Chao C, Carmical JR, Ives KL, Wood TG, Aronson JF, Gomez GA, et al. CD133+ colon cancer cells are more interactive with the tumor microenvironment than CD133-cells. LabInvest (2012) 92:420-36. doi:10.1038/labinvest.2011.185
32. Bar J, Feniger-Barish R, Lukashchuk N, Shaham H, Moskovits N, Goldfinger N, et al. Cancer cells suppress p53 in adjacent fibroblasts. Oncogene (2009) 28:933-6. doi:10.1038/onc.2008.445
33. Mercier I, Casimiro MC, Wang C, Rosenberg AL, Quong J, Minkeu A, et al. Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 down-regulation and RB tumor suppressor functional inactivation: Implications for the response to hormonal therapy. Cancer Biol Ther (2008) 7:1212-25. doi:10.4161/cbt.7.8.6220
34. Pickard A, Cichon AC, Barry A, Kieran D, Patel D, Hamilton P, et al. Inactivation of Rb in stromal fibroblasts promotes epithelial cell invasion. EMBO J (2012) 31:3092-103. doi:10.1038/emboj.2012.153
35. Martinez-Outschoorn UE, Lisanti MP, Sotgia F. Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth. Semin Cancer Biol (2014) 25:47-60. doi:10.1016/j.semcancer.2014.01.005
36. Koukourakis MI, Giatromanolaki A, Harris AL, Sivridis E. Comparison of meta-bolic pathways between cancer cells and stromal cells in colorectal carcinomas: A metabolic survival role for tumor-associated stroma. Cancer Res (2006) 66:632-7. doi:10.1158/0008-5472.can-05-3260
37. Sivridis E, Giatromanolaki A, Koukourakis MI. Proliferating fibroblasts at the invading tumour edge of colorectal adenocarcinomas are associated with endogenous markers of hypoxia, acidity, and oxidative stress. J Clin Pathol (2005) 58:1033-8. doi:10.1136/jcp.2005.026260
38. Martinez-Outschoorn UE, Balliet RM, Rivadeneira DB, Chiavarina B, Pavlides S, Wang C, et al. Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells. Cell Cycle (2010) 9:3256-76. doi:10.4161/cc.9.16.12553
39. Wang X, Allen TD, May RJ, Lightfoot S, Houchen CW, Huycke MM. Enterococcus faecalis induces aneuploidy and tetraploidy in colonic epithelial cells through a bystander effect. CancerRes (2008) 68:9909-17. doi:10.1158/0008-5472.CAN-08-1551
40. Nagasaki T, Hara M, Nakanishi H, Takahashi H, Sato M, Takeyama H. Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: Anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction. Br J Cancer (2014) 110:469-78. doi:10.1038/bjc.2013.748
41. Koshida Y, Kuranami M, Watanabe M. Interaction between stromal fibroblasts and colorectal cancer cells in the expression of vascular endothelial growth factor. J SurgRes (2006) 134:270-7. doi:10.1016/j.jss.2006.02.025
42. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell (2005) 121:335-48. doi:10.1016/j.cell.2005.02.034
43. Bansal R, Tomar T, Ostman A, Poelstra K, Prakash J. Selective targeting of inter-feron gamma to stromal fibroblasts and pericytes as a novel therapeutic approach to inhibit angiogenesis and tumor growth. Mol Cancer Ther (2012) 11:2419-28. doi:10.1158/1535-7163.MCT-11-0758
44. Illemann M, Eefsen RH, Bird NC, Majeed A, Osterlind K, Laerum OD, et al. Tissue inhibitor of matrix metalloproteinase-1 expression in colorectal cancer liver metastases is associated with vascular structures. Mol Carcinog (2015). doi:10.1002/mc.22269
45. Shinagawa K, Kitadai Y, Tanaka M, Sumida T, Kodama M, Higashi Y, et al. Mes-enchymal stem cells enhance growth and metastasis of colon cancer. Int J Cancer (2010) 127:2323-33. doi:10.1002/ijc.25440
46. Shinagawa K, Kitadai Y, Tanaka M, Sumida T, Onoyama M, Ohnishi M, et al. Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer. Int J Cancer (2013) 132:813-23. doi:10.1002/ijc.27735
47. Pernot S, Terme M, Voron T, Colussi O, Marcheteau E, Tartour E, et al. Colorectal cancer and immunity: What we know and perspectives. World J Gastroenterol (2014) 20:3738-50. doi:10.3748/wjg.v20.i14.3738
48. Kinoshita T, Ishii G, Hiraoka N, Hirayama S, Yamauchi C, Aokage K, et al. Fork-head box P3 regulatory T cells coexisting with cancer associated fibroblasts are correlated with a poor outcome in lung adenocarcinoma. Cancer Sci (2013) 104:409-15. doi:10.1111/cas.12099
49. Junttila MR, de Sauvage FJ. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature (2013) 501:346-54. doi:10.1038/nature12626
50. Schellerer VS, Langheinrich M, Hohenberger W, Croner RS, Merkel S, Rau TT, et al. Tumor-associated fibroblasts isolated from colorectal cancer tissues exhibit increased ICAM-1 expression and affinity for monocytes. Oncol Rep (2014) 31:255-61. doi:10.3892/or.2013.2860
51. Calon A, Espinet E, Palomo-Ponce S, Tauriello DV, Iglesias M, Cespedes MV, et al. Dependency of colorectal cancer on a TGF-beta-driven program in stromal cells for metastasis initiation. CancerCell (2012) 22:571-84. doi:10.1016/j.ccr.2012.08.013
52. Li T, Yi S, Liu W, Jia C, Wang G, Hua X, et al. Colorectal carcinoma-derived fibroblasts modulate natural killer cell phenotype and antitumor cytotoxicity. Med Oncol (2013) 30:663. doi:10.1007/s12032-013-0663-z
53. Sasaki S, Baba T, Shinagawa K, Matsushima K, Mukaida N. Crucial involvement of the CCL3-CCR5 axis-mediated fibroblast accumulation in colitis-associated carcinogenesis in mice. Int J Cancer (2014) 135:1297-306. doi:10.1002/ijc.28779
54. Albrengues J, Bourget I, Pons C, Butet V, Hofman P, Tartare-Deckert S, et al. LIF mediates proinvasive activation of stromal fibroblasts in cancer. Cell Rep (2014) 7:1664-78. doi:10.1016/j.celrep.2014.04.036
55. Herrera A, Herrera M, Alba-Castellon L, Silva J, Garcia V, Loubat-Casanovas J, et al. Protumorigenic effects of Snail-expression fibroblasts on colon cancer cells. IntJ Cancer (2014) 134:2984-90. doi:10.1002/ijc.28613
56. Pena C, Cespedes MV, Lindh MB, Kiflemariam S, Mezheyeuski A, Edqvist PH, et al. STC1 expression by cancer-associated fibroblasts drives metastasis of colorectalcancer. CancerRes (2013) 73:1287-97.doi:10.1158/0008-5472.CAN-12-1875
57. Ozdemir BC, Pentcheva-Hoang T, Carstens JL, Zheng X, Wu CC, Simpson TR, et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell (2014) 25:719-34. doi:10.1016/j.ccr.2014.04.005
58. Yamanashi T, Nakanishi Y, Fujii G, Akishima-Fukasawa Y, Moriya Y, Kanai Y, etal. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma. Oncology (2009) 77:53-62. doi:10.1159/000226112
59. Matsusue R, Kubo H, Hisamori S, Okoshi K, Takagi H, Hida K, et al. Hepatic stellate cells promote liver metastasis of colon cancer cells bythe action of SDF-1/CXCR4 axis. Ann Surg Oncol (2009) 16:2645-53. doi:10.1245/s10434-009-0599-x
60. Asahina K. Hepatic stellate cell progenitor cells. J Gastroenterol Hepatol (2012) 27(Suppl 2):80-4. doi:10.1111/j.1440-1746.2011.07001.x
61. Kwak Y, Lee HE, Kim WH, Kim DW, Kang SB, Lee HS. The clinical implication of cancer-associated microvasculature and fibroblast in advanced colorectal cancer patients with synchronous or metachronous metastases. PLoS One (2014) 9:e91811. doi:10.1371/journal.pone.0091811
62. Muller L, Schumacher J, Temel B, Von Seggern L, Tiwari S, Kalthoff H, et al. Increased migration of colorectal cancer cells induced by TNF-alpha-treated stromal fibroblasts from human liver metastases. Cell Commun Signal (2009) 7:A102.doi:10.1186/1478-811x-7-s1-a102
63. Yoshitake N, Fukui H, Yamagishi H, Sekikawa A, Fujii S, Tomita S, et al. Expres-sion of SDF-1 alpha and nuclear CXCR4 predicts lymph node metastasis in colorectal cancer. Br J Cancer (2008) 98:1682-9. doi:10.1038/sj.bjc.6604363
64. Henry LR, Lee HO, Lee JS, Klein-Szanto A, Watts P, Ross EA, et al. Clinical implications of fibroblast activation protein in patients with colon cancer. Clin Cancer Res (2007) 13:1736-41. doi:10.1158/1078-0432.CCR-06-1746
65. Saigusa S, Toiyama Y, Tanaka K, Yokoe T, Okugawa Y, Fujikawa H, et al. Cancer-associated fibroblasts correlate with poor prognosis in rectal cancer after chemoradiotherapy. IntJ Oncol (2011) 38:655-63. doi:10.3892/ijo.2011.906